Most STK11 missense mutations negatively impact upon the LKB1 protein activity (Benci et al., 2016), which then lead to alterations of cancer-associated metabolism, lung cancer initiation, differentiation, local progression and metastatic dissemination (Faubert et al., 2014; Murray et al., 2019). Here, STK11 is linked to lung cancer.